close

Join our Mailing List

Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.

Learn about our new CATALYST Funding Opportunity

Research > Researchers
Dr. Steven Gallinger
Dr. Steven Gallinger
Contact
Dr. Steven Gallinger
Director, PanCuRx Translational Research Initiative

Fortune Okubanjo
Administrative Coordinator
fokubanjo@oicr.on.ca

Director, PanCuRx Translational Research Initiative

Dr. Steven Gallinger is a hepatobiliary/pancreatic (HPB) surgical oncologist at the Princess Margaret Cancer Centre, Professor of Surgery at the University of Toronto and member of the HPB Surgical Oncology Program at both the University Health Network and Mount Sinai Hospital.

External Links

Dr. Gallinger is also the co-Director of the Centre for Cancer Genetics at the Samuel Lunenfeld Research Institute, co-Principal Investigator of the Zane Cohen Familial Gastrointestinal Cancer Registry, Principal Investigator of the Ontario Pancreas Cancer Study, a member of the NIH funded Pancreas Cancer Genetic Epidemiology consortium, a population-based registry of pancreas cancer cases and their families which is now integrated with the International Cancer Genome Consortium (ICGC). His research is focused on gastrointestinal (GI) cancer genetics – both the inherited and acquired molecular aspects of colorectal and pancreatic cancer.

Experience & Education
  • FRCS(C)
  • MD, University of Toronto
  • MSc, University of Toronto
Current Affiliations
  • Surgical Oncologist, University Health Network
  • Member, Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network
  • Senior Investigator, Samuel Lunenfeld Research Institute of Mount Sinai Hospital
  • Member, Institute of Medical Sciences, School of Graduate Studies, University of Toronto
  • Professor, Department of Surgery, University of Toronto
  • Member, Department of Laboratory Medicine and Pathobiology, University of Toronto
  • Co-Director, Zane Cohen Digestive Diseases Clinical Research Centre, Mount Sinai Hospital
  • Active Staff, General Surgery, Toronto General Hospital
  • Co-Director, Centre for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute
Select Publications

See Dr. Gallinger’s recent publications on PubMed or on Google Scholar.

Research Areas
Biology Cancer Origins Early Detection and Diagnosis Treatment
Disease Areas
Pancreatic
Awards
  • University Health Network, The Joseph and Wolf Lebovic Chair in HPB Surgery, 2014
  • Oakdale Golf and Country Club/George Knudson Research Chair in Gastrointestinal Cancer, 2008
  • University of Toronto, Department of Surgery, 4th Annual Charles H. Tator Surgeon-Scientist Mentoring Award, 2005
  • University of Edinburgh, James IV Travelling Fellowship, 2005
  • University of Toronto, Department of Surgery, Lister Prize, 2003
  • Israel Cancer Research Fund, Scientific Award, 2001
  • Mount Sinai Hospital, Lloyd S. Fogler Award, 2000
  • University of Toronto, Department of Surgery, George Armstrong Peters Prize, 1995
Opportunities to Collaborate

To collaborate with Dr. Gallinger, please contact him directly.

Collaborate with us

Visit OICR’s Collaborative Research Resources directory for more opportunities to collaborate with OICR researchers.

Patents
  • Animal Model of the Human Immune System.  Gallinger S, Hozumi N, Roder J, Sandhu J, Shpitz B: US Patent –Patent #08/102,905. 1996.
  • Assessment of Risk for Colorectal Cancer. Cotterchio M, Gallinger S, Greenwood C, Hudson TJ, Zanke BW, Phillips M, Sundararajan S, Montpetit A, Laflamme P, Ferretti V.  Patent # PCT/CA 2008/000424. Pub # WO/2008/106785. 2008.
In the News
OICR appoints Dr. Steven Gallinger as Head, Clinical Translation
OICR appoints Dr. Steven Gallinger as Head, Clinical Translation
Mar 18, 2021
 Genome sequencing delivers real-time results for hard-to-treat pancreatic cancer
Genome sequencing delivers real-time results for hard-to-treat pancreatic cancer
Jul 11, 2022